Company Profile

Mesoblast Ltd. (NASDAQ: MESO)
3:59 PM EST, 12/08/17
Last: $5.30 Change: +0.07 %Change: +1.34% Volume: 70,825
Detailed Quote
Open: $5.23   Volume: 70,825
High: $5.75   Yield(%) n/a
Low: $5.15   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 498.84M
EPS ($) n/a   Shares Out: 94.12M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -3.64
% Price Change (last 13 weeks): -9.86
% Price Change (last 26 weeks): -34.57
% Price Change (last 52 weeks): n/a
% Price Change (year to date): -1.85
Management Effectiveness
Return on Equity (%): -11.97
Return on Assets (%): -8.60
Return on Invested Capital (%): -12.00
Profitability
Gross Profit Margin (%): -239.64
Net Profit Margin (%): -2,255.00
Operating Profit Margin (%): -3,160.51
Price & Volume
50-day Moving Average: $5.63
200-day Moving Average: $7.44
Avg. Daily Vol. (last 50 days): 31,775
Avg. Daily Vol. (last 200 days): 33,946
52-wk high: $12.50
52-wk low: $4.46
Bid: $4.19
Ask: $6.00
Company Information
Mesoblast Ltd. engages in the research, development, and market of pharmaceutical products. Its medicines target the cardiovascular conditions, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.
Mesoblast Ltd.
55 Collins Street Level 38
Melbourne VI 3000

Phone: 61.3.9639.6036
Fax: 61.3.9639.6030
http://www.mesoblast.com
Per Share Data
Earnings (1year) ($): -0.70
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 5.90
Cash Flow ($): -0.80
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 159.10
Price/Book (x): 0.90
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 3.51
Current Ratio (x): 3.51
LT Debt/Equity (x): 0.00
Total Debt/Equity (x): 0.00



Quotes displayed with 15 minutes delay. Market data provided by ICE Data Services ICE Limitations. Powered and implemented by FactSet. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Hemscott equity data provided by Morningstar, Inc. Earnings Calendar and Events Data provided by Wall Street Horizon. © 2017 Wall Street Horizon, Inc.